Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Curative Surgery
100%
Lung Cancer
100%
Postsurgical
100%
Non-small Cell Lung Cancer (NSCLC)
83%
Cancer Recurrence
77%
Translocator Protein
66%
Gut Health
66%
Inflammatory Bowel Disease
66%
Mycotoxins
66%
Health Implications
66%
Lung Cancer Recurrence
66%
Postoperative Recurrence
63%
NHS Trusts
63%
Surgical Resection
44%
Recurrence Pattern
44%
Curative Intent
44%
After Surgery
44%
Early-stage Lung Cancer
44%
Recurrence Rate
44%
Mitophagy
37%
Ca2+ Homeostasis
33%
MicroRNA
33%
Recurrence Risk
33%
Density Curve
33%
Late Recurrence
33%
Mitochondrial Retrograde Signaling
33%
Long-term Survival
33%
Positively Skewed
33%
Surgical Treatment
33%
Distant Metastasis
33%
Neurotoxicity
33%
Mouse Embryonic Stem Cells (mESCs)
33%
NLRP3 Inflammasome
33%
Local Site
33%
Prodromal
33%
Microglia
33%
Smoking Status
33%
Lung Cancer Outcomes
33%
Surgical Referrals
33%
Comorbidity
33%
District Hospital
33%
Referral Center
33%
Age Influence
33%
Demographic Influences
30%
Ever Smokers
25%
Lung Cancer Surgery
22%
Surgical Centre
22%
No Significant Difference
22%
Consecutive Patients
22%
Retrospective Analysis
22%
Biochemistry, Genetics and Molecular Biology
Translocator Protein
66%
Homeostasis
40%
Mitophagy
37%
MicroRNA
33%
Embryonic Stem Cell
33%
NLRP3 Inflammasome
33%
Mitochondrion
13%
Dicer
11%
Calcium Signaling
11%
Cell Death
6%
Transcriptome
6%
Redox Stress
6%
Positive Feedback
6%
Autophagy
6%
Dopamine
6%
Genetics
6%
Neurotoxin
6%
Ubiquitin
6%
Transcription Factors
6%
Protein Kinases
6%
Lysosome
6%